Chi-Mu Chuang

835 total citations
21 papers, 576 citations indexed

About

Chi-Mu Chuang is a scholar working on Surgery, Reproductive Medicine and Molecular Biology. According to data from OpenAlex, Chi-Mu Chuang has authored 21 papers receiving a total of 576 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Surgery, 8 papers in Reproductive Medicine and 7 papers in Molecular Biology. Recurrent topics in Chi-Mu Chuang's work include Ovarian cancer diagnosis and treatment (7 papers), Intraperitoneal and Appendiceal Malignancies (4 papers) and Immunotherapy and Immune Responses (4 papers). Chi-Mu Chuang is often cited by papers focused on Ovarian cancer diagnosis and treatment (7 papers), Intraperitoneal and Appendiceal Malignancies (4 papers) and Immunotherapy and Immune Responses (4 papers). Chi-Mu Chuang collaborates with scholars based in Taiwan, United States and Norway. Chi-Mu Chuang's co-authors include Chien‐Fu Hung, Archana Monie, Annie A. Wu, Chih‐Ping Mao, T.‐C. Wu, Peng‐Hui Wang, Ming-Shyen Yen, Yi‐Jen Chen, Hua-Hsi Wu and Chiung‐Ru Lai and has published in prestigious journals such as PLoS ONE, Cancer Research and Clinical Cancer Research.

In The Last Decade

Chi-Mu Chuang

21 papers receiving 570 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chi-Mu Chuang Taiwan 15 215 165 118 112 101 21 576
Canhui Cao China 16 443 2.1× 128 0.8× 213 1.8× 77 0.7× 99 1.0× 55 821
Lihui Wei China 17 262 1.2× 63 0.4× 128 1.1× 106 0.9× 415 4.1× 83 857
Haruka Nishida Japan 12 205 1.0× 117 0.7× 152 1.3× 32 0.3× 82 0.8× 37 472
Hans Henning von Horsten Germany 9 350 1.6× 124 0.8× 80 0.7× 404 3.6× 16 0.2× 15 784
Liying Gu China 15 271 1.3× 46 0.3× 96 0.8× 26 0.2× 204 2.0× 35 609
Biying Zheng China 18 311 1.4× 129 0.8× 130 1.1× 14 0.1× 258 2.6× 33 728
Suping Han China 17 389 1.8× 175 1.1× 123 1.0× 70 0.6× 127 1.3× 30 709
Felicitas Bossler Germany 7 388 1.8× 170 1.0× 237 2.0× 15 0.1× 263 2.6× 7 720
Joseph Heintz United States 5 214 1.0× 98 0.6× 119 1.0× 82 0.7× 49 0.5× 8 453
Yoshiaki Maru Japan 14 257 1.2× 65 0.4× 346 2.9× 161 1.4× 77 0.8× 26 702

Countries citing papers authored by Chi-Mu Chuang

Since Specialization
Citations

This map shows the geographic impact of Chi-Mu Chuang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chi-Mu Chuang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chi-Mu Chuang more than expected).

Fields of papers citing papers by Chi-Mu Chuang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chi-Mu Chuang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chi-Mu Chuang. The network helps show where Chi-Mu Chuang may publish in the future.

Co-authorship network of co-authors of Chi-Mu Chuang

This figure shows the co-authorship network connecting the top 25 collaborators of Chi-Mu Chuang. A scholar is included among the top collaborators of Chi-Mu Chuang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chi-Mu Chuang. Chi-Mu Chuang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Shen, Yao, Jiaxin Hong, Shiho Asaka, et al.. (2020). Inhibition of the MYC-Regulated Glutaminase Metabolic Axis Is an Effective Synthetic Lethal Approach for Treating Chemoresistant Ovarian Cancers. Cancer Research. 80(20). 4514–4526. 60 indexed citations
2.
Huang, Wen-Sheng, Chi-Mu Chuang, Gann Ting, et al.. (2019). A phase 0 study of the pharmacokinetics, biodistribution, and dosimetry of 188Re-liposome in patients with metastatic tumors. EJNMMI Research. 9(1). 46–46. 22 indexed citations
4.
Liu, Chia‐Hao, et al.. (2018). Alpha-fetoprotein-producing ovarian clear cell adenocarcinoma with fetal gut differentiation: a rare case report and literature review. Journal of Ovarian Research. 11(1). 52–52. 15 indexed citations
5.
Liu, Chia‐Hao, et al.. (2018). Neurofibroma involving obturator nerve mimicking an adnexal mass: a rare case report and PRISMA-driven systematic review. Journal of Ovarian Research. 11(1). 14–14. 6 indexed citations
6.
Sung, Pi‐Lin, Kuo‐Chang Wen, Yi‐Jen Chen, et al.. (2017). The frequency of cancer predisposition gene mutations in hereditary breast and ovarian cancer patients in Taiwan: From BRCA1/2 to multi-gene panels. PLoS ONE. 12(9). e0185615–e0185615. 19 indexed citations
7.
Chang, Chia‐Ming, et al.. (2017). 188Re-Liposome Can Induce Mitochondrial Autophagy and Reverse Drug Resistance for Ovarian Cancer: From Bench Evidence to Preliminary Clinical Proof-of-Concept. International Journal of Molecular Sciences. 18(5). 903–903. 36 indexed citations
8.
Chang, Chia‐Ming, Chi-Mu Chuang, Mong‐Lien Wang, et al.. (2016). Gene Set−Based Integrative Analysis Revealing Two Distinct Functional Regulation Patterns in Four Common Subtypes of Epithelial Ovarian Cancer. International Journal of Molecular Sciences. 17(8). 1272–1272. 13 indexed citations
9.
Chang, Chia‐Ming, Chi-Mu Chuang, Mong‐Lien Wang, et al.. (2016). Gene Set-Based Functionome Analysis of Pathogenesis in Epithelial Ovarian Serous Carcinoma and the Molecular Features in Different FIGO Stages. International Journal of Molecular Sciences. 17(6). 886–886. 9 indexed citations
10.
Wu, Chen‐Yi, et al.. (2015). The risk of irritable bowel syndrome in patients with endometriosis during a 5-year follow-up: a nationwide population-based cohort study. International Journal of Colorectal Disease. 30(7). 907–912. 21 indexed citations
11.
Chang, Wen‐Hsun, Yi‐Jen Chen, Cheng‐Chang Chang, et al.. (2015). Comparison of single-incision mini-slings (Ajust) and standard transobturator midurethral slings (Align) in the management of female stress urinary incontinence: A 1-year follow-up. Taiwanese Journal of Obstetrics and Gynecology. 54(6). 726–730. 7 indexed citations
12.
Shen, Yao, et al.. (2015). Intraperitoneal delivery of a novel liposome-encapsulated paclitaxel redirects metabolic reprogramming and effectively inhibits cancer stem cells in Taxol(®)-resistant ovarian cancer.. PubMed. 7(5). 841–55. 24 indexed citations
13.
Horng, Huann-Cheng, Ben-Shian Huang, Hsu‐Dong Sun, et al.. (2014). Primary fallopian tube cancer: Domestic data and up-to-date review. Taiwanese Journal of Obstetrics and Gynecology. 53(3). 287–292. 24 indexed citations
14.
Yang, Ming, Tao Yu, Yingying Wang, et al.. (2014). Intraperitoneal delivery of paclitaxel by poly(ether-anhydride) microspheres effectively suppresses tumor growth in a murine metastatic ovarian cancer model. Drug Delivery and Translational Research. 4(2). 203–209. 14 indexed citations
15.
Chuang, Chi-Mu, Yiing‐Jeng Chou, Ming-Shyen Yen, et al.. (2012). The Role of Secondary Cytoreductive Surgery in Patients with Recurrent Epithelial Ovarian, Tubal, and Peritoneal Cancers: A Comparative Effectiveness Analysis. The Oncologist. 17(6). 847–855. 12 indexed citations
16.
Chuang, Chi-Mu, Archana Monie, Chien‐Fu Hung, & T.‐C. Wu. (2010). Treatment with Imiquimod enhances antitumor immunity induced by therapeutic HPV DNA vaccination. Journal of Biomedical Science. 17(1). 32–32. 36 indexed citations
17.
Chuang, Chi-Mu, Archana Monie, Annie A. Wu, Sara I. Pai, & Chien‐Fu Hung. (2009). Combination of Viral Oncolysis and Tumor-Specific Immunity to Control Established Tumors. Clinical Cancer Research. 15(14). 4581–4588. 16 indexed citations
18.
Chuang, Chi-Mu, Archana Monie, Annie A. Wu, Chih‐Ping Mao, & Chien‐Fu Hung. (2009). Treatment with LL-37 Peptide Enhances Antitumor Effects Induced by CpG Oligodeoxynucleotides Against Ovarian Cancer. Human Gene Therapy. 20(4). 303–313. 85 indexed citations
19.
Chuang, Chi-Mu, Archana Monie, Annie A. Wu, & Chien‐Fu Hung. (2009). Combination of apigenin treatment with therapeutic HPV DNA vaccination generates enhanced therapeutic antitumor effects. Journal of Biomedical Science. 16(1). 49–49. 47 indexed citations
20.
Chuang, Chi-Mu, et al.. (2008). Enhancing therapeutic HPV DNA vaccine potency through depletion of CD4+CD25+ T regulatory cells. Vaccine. 27(5). 684–689. 43 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026